Comparative Efficacy, Safety, and Cost‐Utility of DPP‐4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real‐World Clinical and Economic Outcomes
2026Journal of Diabetes ResearchJournalOpen access
10.1155/jdr/8464330Full text2 citations